Digital health exits 2016 YTD: 112 digital health acquisitions and two IPOs
2016 YTD digital health funding: 10 things you should know
Four behavior change lessons from a low tech solution
The genomics inflection point: Implications for healthcare
The genomics industry has tremendous potential to move the needle in health. Delivering on the promise of genomics depends on three main factors—many of which are within the purview of digital health. Through our survey of one thousand consumers, we provide novel data and insights regarding adoption, willingness to pay for specific use cases, and explore concerns around privacy and ownership.
Digital health funding 2016 midyear review
After years of record-breaking venture funding, digital health finally hit its stride in a year when everyone expected funding to decline. In the first half of 2016, slightly over $2B filled company coffers–on track with both 2014 and 2015.
Why digital health should care about genomics
Thanks to ongoing advancements in the field of genomics and unprecedented interest from a range of stakeholders including health systems, researchers, the government, and the general public, genetic testing has the potential to reshape healthcare through personalized interventions. Delivering on the promise of genomics is dependent upon three main factors, most of which are within the purview of digital health.
How you’re promoting gender bias on teams—and how to stop.
Biases can happen at any stage of employment by even the most ‘progressive’ of employers—from hiring to performance reviews. They skew the balance in not just who is on your team but who makes up leadership—and how and what decisions are made for the company. So what can you do to overcome unconscious prejudice?
What 140 CEOs want you to know about digital health
What’s the status of the biggest API in healthcare?
Join our mailing list.
The most popular digital health newsletter. Subscribe to the Rock Weekly to be the first to know about our newest reports.